Literature DB >> 2260622

Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition.

J R Diamond1, S Anderson.   

Abstract

Chronic aminonucleoside nephrosis is variably associated with tubulointerstitial damage, depending on the route and frequency of drug administration. Recently, different groups have shown this injurious tubulointerstitial process to be reversible, coinciding with the resolution of heavy proteinuria to normal values. The authors have previously shown that a single jugular intravenous administration of puromycin aminonucleoside (PA) to male Munich-Wistar rats produces a triphasic pattern of glomerular injury and proteinuria, which culminates in focal glomerulosclerosis 70 weeks after drug administration. The authors now report the later progression of the tubulointerstitial morphologic abnormalities associated with acute nephrosis (phase I), despite spontaneous resolution of glomerular injury during the intermediate period (phase II) in this model. Although treatment of rats with the angiotensin I converting enzyme inhibitor enalapril (50 mg/l drinking water) over the 70-week period did not affect the magnitude of proteinuria during the acute nephrotic phase, enalapril prevented the recurrence of proteinuria (phase III), as well as significantly reducing the severity of interstitial fibrosis, extent of tubular dilatation, and number of intratubular casts on semiquantitative scoring at the conclusion of the study. In addition, enalapril-treated rats had less low-molecular-weight protein excretion during the recurrent phase of proteinuria, suggesting a preservation of tubular functional capacity to reabsorb these proteins. In vitro cytotoxicity studies showed only the glomerular visceral epithelial cell to be sensitive to PA, in contrast with rat tubular epithelium and other cellular controls. Although the exact pathogenetic mechanism responsible for the development of the tubulointerstitial damage remains unknown, PA in vitro does not adversely affect rat tubular epithelium; there is however a clear correlation between the magnitude of recurrent proteinuria and the severity of tubulointerstitial morphologic abnormalities, as suggested by the beneficial effect of converting enzyme inhibition on both of these untoward processes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2260622      PMCID: PMC1877718     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  The production of chronic renal disease in rats by a single intravenous injection of aminonucleoside of puromycin and the effect of low dosage continuous hydrocortisone.

Authors:  R LANNIGAN
Journal:  Br J Exp Pathol       Date:  1963-06

2.  Micropuncture study of tubular transport of albumin in rats with aminonucleoside nephrosis.

Authors:  D E Oken; S C Cotes; C W Mende
Journal:  Kidney Int       Date:  1972       Impact factor: 10.612

3.  An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosis.

Authors:  G B Ryan; M J Karnovsky
Journal:  Kidney Int       Date:  1975-10       Impact factor: 10.612

4.  Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis.

Authors:  R J Glasser; J A Velosa; A F Michael
Journal:  Lab Invest       Date:  1977-05       Impact factor: 5.662

5.  Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome.

Authors:  S Anderson; J R Diamond; M J Karnovsky; B M Brenner
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

6.  Effects of surgery on plasma volume and salt and water excretion in rats.

Authors:  D A Maddox; D C Price; F C Rector
Journal:  Am J Physiol       Date:  1977-12

7.  Adverse effect of indomethacin in experimental chronic nephrosis.

Authors:  C Kleinknecht; D Laouari; M C Gubler; F Gros
Journal:  Int J Pediatr Nephrol       Date:  1983-06

8.  Ferritin deposition in the glomerular deposits of focal glomerular sclerosis in the rat.

Authors:  C Melcion; J Smith; V Cattell
Journal:  J Pathol       Date:  1984-09       Impact factor: 7.996

9.  Experimental focal segmental glomerulosclerosis: correlation with protein excretion, glomerular filtration rate, and renal plasma flow.

Authors:  M Chandra; M Susin; S Teichberg; M McVicar
Journal:  Pediatr Res       Date:  1984-11       Impact factor: 3.756

10.  Effect of blood pressure on the progress of renal deterioration in rats with renal mass reduction.

Authors:  H Tsuruda; S Okuda; K Onoyama; Y Oh; M Fujishima
Journal:  J Lab Clin Med       Date:  1986-01
View more
  14 in total

1.  Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor.

Authors:  G Wolf; F N Ziyadeh; F Thaiss; J Tomaszewski; R J Caron; U Wenzel; G Zahner; U Helmchen; R A Stahl
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 2.  Is there any reason to lower proteinuria in a child with nephrotic-range proteinuria who is not clinically edematous?

Authors:  D Kees-Folts
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

3.  Effects of xanthine oxidase inhibition with febuxostat on the development of nephropathy in experimental type 2 diabetes.

Authors:  Radko Komers; Bei Xu; Jennifer Schneider; Terry T Oyama
Journal:  Br J Pharmacol       Date:  2016-07-27       Impact factor: 8.739

4.  Time course and localization of endothelin-1 gene expression in a model of renal disease progression.

Authors:  I Bruzzi; D Corna; C Zoja; S Orisio; E L Schiffrin; D Cavallotti; G Remuzzi; A Benigni
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

5.  Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.

Authors:  S Kagami; W A Border; D E Miller; N A Noble
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

6.  Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin).

Authors:  R Pichler; C M Giachelli; D Lombardi; J Pippin; K Gordon; C E Alpers; S M Schwartz; R J Johnson
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

7.  Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta.

Authors:  G Wolf; E Mueller; R A Stahl; F N Ziyadeh
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

8.  Beneficial effect of triple treatment plus immunoglobulin in experimental nephrotic syndrome.

Authors:  Sema Akman; Salih Kalay; Bahar Akkaya; Mustafa Koyun; Halide Akbaş; Yunus Emre Baysal; Ayfer Gur Guven
Journal:  Pediatr Nephrol       Date:  2009-02-18       Impact factor: 3.714

9.  Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats.

Authors:  C L Jones; S Buch; M Post; L McCulloch; E Liu; A A Eddy
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

10.  Restoration of podocyte structure and improvement of chronic renal disease in transgenic mice overexpressing renin.

Authors:  Anne-Cécile Huby; Maria-Pia Rastaldi; Kathleen Caron; Oliver Smithies; Jean-Claude Dussaule; Christos Chatziantoniou
Journal:  PLoS One       Date:  2009-08-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.